Stuart Holman

Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration

Michael D. Woodrow, Stuart P. Ballantine, Michael D. Barker et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 56 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Pyrazolopyridines as potent PDE4B inhibitors: 5-Heterocycle SAR

Charlotte Mitchell, Stuart P. Ballantine, Diane M. Coe et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 40 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Enantiospecific synthesis of the potent anti-herpetic carbocyclic 9-(2′deoxy-2′-flouro-β-D-arabinofuranosyl) guanine (+)CAFG from arsiteromycin

Alan D. Borthwick, Keith Biggadike, Stuart Holman et al. · Tetrahedron Letters · 1990 · 12 citations

Pharmacy, Medicinal Chemistry, Pharmacology +6

Synthesis and Structure-Activity Relationships of a Series of Penicillin-Derived HIV Proteinase Inhibitors: Heterocyclic Ring Systems Containing P1' and P2' Substituents

John R. Kitchin, Richard C. Bethell, N. Cammack et al. · Journal of Medicinal Chemistry · 1994 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Preparation of β-amino alcohols by carbon–carbon bond formation using substituted lithiomethylpyrrolidines

Iain Coldham, Stuart Holman, M. M. S. LANG‐ANDERSON · Journal of the Chemical Society Perkin Transactions 1 · 1997 · 10 citations

Natural Sciences, Chemistry, Organic Chemistry +8